Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 54.30B | 12.1x | -1.55 | ZAC 12,201 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5% Upside | Upgrade to Pro+ | |
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 27.59B | 10.8x | 0.01 | ZAC 1,489 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.53B | 13.2x | ZAC 8,900 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.53B | 13.2x | 0.73 | ZAC 1,442 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Adcock Ingram Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 7.25B | 9.6x | -1.06 | ZAC 4,925 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | ZAR 506.86M | 27x | 0.19 | ZAC 81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numeral | Johannesburg | Healthcare | Biotechnology & Medical Research | ZAR 248.09M | -113.6x | ZAC 1 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 213.05M | 253.5x | ZAC 300 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |